(Q36727459)

15 August 2017

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2 (English)

1 reference

15 August 2017

1 reference

1 reference

10

Steven A Narod

1 reference

15 August 2017

John R McLaughlin

1

1 reference

15 August 2017

Barry Rosen

2

1 reference

15 August 2017

Joel Moody

3

1 reference

15 August 2017

Tuya Pal

4

1 reference

15 August 2017

Isabel Fan

5

1 reference

15 August 2017

Patricia A Shaw

6

1 reference

15 August 2017

Harvey A Risch

7

1 reference

15 August 2017

Thomas A Sellers

8

1 reference

15 August 2017

Ping Sun

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

20 December 2012

1 reference

Journal of the National Cancer Institute

15 August 2017

1 reference

15 August 2017

105

1 reference

15 August 2017

2

1 reference

15 August 2017

141-148

1 reference

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

Improved survival in BRCA2 carriers with ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

Improved survival in women with BRCA-associated ovarian carcinoma

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3611851

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS494

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer

21 January 2018

1 reference

12 December 2020

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

1 reference

12 December 2020

Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group

1 reference

12 December 2020

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations

1 reference

12 December 2020

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJS494

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23257159

1 reference